GenomOncology
Brad Wertz is the current CEO and Chairman at GenomOncology. Brad has over 15 years of experience in the healthcare industry, including previous positions as President & COO at Rosetta and COO at Brulant. Brad has also served as a co-founder at Xteric Technology Group. Brad holds a bachelor's degree in Business Administration from the University of Michigan.
Some direct reports include Justin Yeakley - VP, Product Development, Ian Maurer - Chief Technology Officer, and Joe McCrone - SVP, Client Services.
This person is not in any offices
GenomOncology
GenomOncology provides the healthcare community with data-driven insights to improve cancer care. GenomOncology strengthens your precision oncology program by transforming valuable, but unusable data, into actionable oncology treatment options and strategic insights to drive measurable results.